Next Generation Sequencing (NGS) Market Segmentation,Application,Technology & Market Analysis Research Report 2020
COMPLETE REPORT DETAILS @ https://www.wiseguyreports.com/reports/33821-next-generation-sequencing-ngs-global-market-forecast-to-2020
A decade has gone, since the first human genome has been sequenced and sequencing technology has come a long way from the time of introduction as Next generation Sequencing (NGS) has revolutionized the way the human genomes are being sequenced now a days. The time and cost to sequence has tremendously reduced since the first human genome was sequenced, which took a decade time and around $3 billion. According to experts, in the coming years, a human genome can be sequenced at a cost of $1,000 in one to two days. In the last five years the sequencing cost has rapidly reduced and this is supposed to have a huge impact on the NGS market in the coming years.
For more information or any query mail at sales@wiseguyreports.com
The global Next Generation Sequencing market is valued to be XX million in 2013 and poised to grow at a CAGR of XX% to reach $4,892 million by 2020. The NGS market is classified based on products, technology, end users, application and geography. The global NGS products are further divided into instruments and consumables, services and workflow products. The NGS technology is segmented into targeted resequencing, whole exome sequencing, RNA sequencing, whole genome sequencing, ChIP sequencing, de novo sequencing and methyl sequencing. The NGS market by end users is divided into academic research laboratories, hospitals and clinics, biotech and pharmaceuticals and other end users, which include nonprofit organizations and commercial labs.
The application of NGS market is classified into clinical and non-clinical applications. By application type, the market is broken down into oncology, genetic screening, infectious diseases, drug and biomarker discovery, molecular epidemiology, agriculture and animal research and other applications. Further, the NGS market is separated by geographical regions into North America, Europe, Asia-pacific and Rest of the World
GET A SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/33821-next-generation-sequencing-ngs-global-market-forecast-to-2020
Table Of Contents – Major Key Points
1 EXECUTIVE SUMMARY 17
2 INTRODUCTION 25
2.1 KEY TAKE AWAYS 25
2.2 REPORT DESCRIPTION 25
2.3 MARKETS COVERED 26
2.4 STAKEHOLDERS 28
2.5 RESEARCH METHODOLOGY 28
2.5.1 MARKET SIZE ESTIMATION 29
2.5.2 MARKET CRACKDOWN AND DATA TRIANGULATION 32
2.5.3 SECONDARY SOURCES 33
2.5.4 PRIMARY SOURCES 34
2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES 34
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES 35
2.5.7 ASSUMPTIONS 35
3 MARKET ANALYSIS 36
3.1 INTRODUCTION 36
3.2 MARKET SEGMENTATION 37
3.3 FACTORS INFLUENCING MARKET 40
3.3.1 DRIVERS AND OPPORTUNITIES 41
3.3.1.1 REDUCED COST AND HIGH SPEED 41
3.3.1.2 INCREASED USAGE IN CLINICAL DIAGNOSIS 41
3.3.1.3 SWITCH TO NGS FROM MICROARRAY TECHNOLOGY 42
3.3.1.4 NEW & EMERGING APPLICATIONS OF NGS TECHNOLOGY 43
3.3.1.5 GROWTH OF PERSONALIZED MEDICINE AND BIOMARKER SEGMENTS 44
3.3.1.6 RISING DEMAND FOR NGS DISCOVERY TECHNOLOGY 45
3.3.1.7 INCREASED MEDICAL SPENDING 46
3.3.1.8 RISE IN INCIDENCE OF CHRONIC DISEASE 46
3.3.1.9 EMERGING TECHNOLOGIES 47
3.3.2 RESTRAINTS AND THREATS 52
3.3.2.1 COMPLICATIONS IN NGS DATA STORAGE 52
3.3.2.2 STANDARDIZATION OF NGS FOR DIAGNOSTIC APPLICATION 53
3.3.2.3 GRANTS AND FUNDING FOR NGS INFRASTRUCTURE 53
3.3.2.4 LACK OF SKILLED LABOR 54
3.3.2.5 HUGE DATA INTERPRETATION OF NGS 54
3.3.2.6 ETHICAL AND LEGAL ISSUES TO NGS 55
3.3.3 BURNING ISSUES 56
3.3.3.1 REDUCED COST LEADS TO COMPLEXITY IN DATA STORAGE 56
3.4 PORTER’S FIVE FORCE ANALYSIS 57
3.4.1 THREAT OF NEW ENTRANTS 57
3.4.2 THREAT OF SUBSTITUTES 57
3.4.3 BARGAINING POWER OF SUPPLIERS 57
3.4.4 BARGAINING POWER OF BUYERS 58
3.4.5 COMPETITIVE RIVALRY 59
3.5 REGULATORY AFFAIRS 59
3.5.1 U.S. 59
3.5.2 EUROPE 60
3.5.3 CHINA 61
3.6 MARKET SHARE ANALYSIS BY MAJOR PLAYERS 62
4 NEXT GENERATION SEQUENCING MARKET, BY PRODUCTS 64
4.1 INTRODUCTION 64
4.2 INSTRUMENTS AND CONSUMBALES 66
4.3 SERVICES 68
4.4 WORKFLOW PRODUCTS 70
5 NEXT GENERATION SEQUENCING MARKET VALUE AND VOLUME ANALYSIS, BY TECHNOLOGY 73
5.1 INTRODUCTION 73
5.1.1 NGS PLATFORM INSTALLATION BASE 74
5.1.2 NGS MARKET REVENUE, BY TECHNOLOGY 76
5.1.3 NGS SAMPLE MARKET VOLUME, BY TECHNOLOGY 77
5.2 TARGETED RESEQUENCING 78
5.2.1 TARGETED RESEQUENCING MARKET REVENUE, BY REGION 79
5.2.2 TARGETED RESEQUENCING SAMPLES MARKET VOLUME, BY REGION 80
5.3 WHOLE EXOME SEQUENCING 80
5.3.1 WHOLE EXOME SEQUENCING MARKET REVENUE, BY REGION 81
5.3.2 WHOLE EXOME SEQUENCING SAMPLES MARKET VOLUME, BY REGION 82
5.4 RNA SEQUENCING 82
5.4.1 RNA SEQUENCING MARKET REVENUE, BY REGION 84
5.4.2 RNA SEQUENCING SAMPLES MARKET VOLUME, BY REGION 85
5.5 WHOLE GENOME SEQUENCING 85
5.5.1 WHOLE GENOME SEQUENCING MARKET REVENUE, BY REGION 87
5.5.2 WHOLE GENOME SEQUENCING SAMPLES MARKET VOLUME, BY REGION 88
5.6 CHIP SEQUENCING 88
5.6.1 CHIP SEQUENCING MARKET REVENUE, BY REGION 89
5.6.2 CHIP SEQUENCING SAMPLES MARKET VOLUME, BY REGION 90
5.7 DE NOVO SEQUENCING 90
5.7.1 DE NOVO SEQUENCING MARKET REVENUE, BY REGION 92
5.7.2 DE NOVO SEQUENCING SAMPLES MARKET VOLUME, BY REGION 93
5.8 METHYL SEQUENCING 93
5.8.1 METHYL SEQUENCING MARKET REVENUE, BY REGION 94
5.8.2 METHYL SEQUENCING SAMPLES MARKET VOLUME, BY REGION 95
6 NEXT GENERATION SEQUENCING MARKET, BY END USERS/LABORATORIES 96
6.1 INTRODUCTION 96
6.1.1 NGS MARKET REVENUE BY END-USERS/ LABORATORIES 98
6.1.2 NGS SAMPLES MARKET VOLUME BY END-USERS/ LABORATORIES 99
6.1.3 NGS LABORATORIES VOLUME MARKET BY END- USERS 100
6.1.4 NGS LABORATORIES VOLUME MARKET BY LAB TYPE 101
6.1.5 NGS LABORATORIES VOLUME MARKET BY REGION 102
6.2 ACADEMIC RESEARCH 102
6.2.1 ACADEMIC RESEARCH MARKET REVENUE BY REGION 103
6.2.2 ACADEMIC RESEARCH SAMPLES MARKET VOLUME BY REGION 104
6.3 HOSPITALS AND CLINICS 104
6.3.1 HOSPITALS AND CLINICS MARKET REVENUE BY REGION 106
6.3.2 HOSPITALS AND CLINICS SAMPLES MARKET VOLUME BY REGION 107
6.4 BIOTECH/PHARMACEUTICALS 107
6.4.1 BIOTECH/PHARMACEUTICALS MARKET REVENUE BY REGION 109
6.4.2 BIOTECH/PHARMACEUTICALS SAMPLES MARKET VOLUME BY REGION 110
6.5 OTHER END USERS 111
6.5.1 OTHER END-USERS MARKET REVENUE BY REGION 112
6.5.2 OTHER END-USERS SAMPLES MARKET VOLUME BY REGION 113
Continue....
For more information or any query mail at sales@wiseguyreports.com
CHECK DISCOUNT ON THIS REPORT @ https://www.wiseguyreports.com/check-discount/33821-next-generation-sequencing-ngs-global-market-forecast-to-2020
Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
16468459349
email us here
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
